UNSPSC 51283921: Sulfametomidine or sulfamethomidine

This classification denotes a sulfonamide anti-infective agent with the molecular formula C12H14N4O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 940ZL3AHKB, chemically known as sulfanilamide, n(sup 1)-(6-methoxy-2-methyl-4-pyrimidinyl)- but generally known as sulfamethomidine, which bears US NIH Compound Identifier 19596. European Medicines Agency schedules Sulfametomidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10713MIG.

UNSPSC 51283921 Sulfametomidine or sulfamethomidine, a Commodity code, shows minimal alignment between its nominal scope and recent state and local procurement activity. The code nominally covers a single pharmaceutical compound, yet the recent opportunities tagged to this code span naloxone dispensing systems, direct-to-manufacturer prescription programs, emergency medical supplies for fire departments, and multi-source generic pharmaceuticals and OTC products—none of which are sulfametomidine-specific formulations. This classification mismatch suggests the code either has been misapplied to these solicitations or captures a broader range of medical supply and pharmaceutical procurement than its name alone indicates. The actual work being procured under recent postings centers on pharmaceutical supply contracts, emergency medical consumables, and state pharmacy benefit program management rather than a single active pharmaceutical ingredient.

Recent opportunities originate from diverse issuing bodies including a Florida county health department (Seminole County), a state health agency (Texas Health and Human Services Commission), a municipal fire department (City of Tampa), and a multistate cooperative purchasing vehicle (Minnesota Multistate Cooperative Purchasing Alliance serving state and local governments across Minnesota and Oregon). Representative solicitations include Seminole County's IFB 60459723LAS (due July 26, 2023) for naloxone and drug deactivation systems with annual volumes of 1,900 units and 800 units respectively; the City of Tampa's ITB 26P00145 (due March 13, 2026) for 169 line items of medical and first aid supplies totaling an estimated $700,000 with a five percent small local business enterprise discount; and the Minnesota Multistate Cooperative Purchasing Alliance RFP S1070000015802 (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products to be distributed across state and local facilities. Geographic activity spans Florida, Texas, Minnesota, and Oregon. The code shows significant recent posting activity across state and local jurisdictions, though the mismatch between code definition and actual procurement scope suggests business development professionals should verify commodity classification against specific RFP or IFB documents before committing pursuit resources.